Pharmafile Logo
Pharmafocus logo
Advanced Search

New Europe-wide approach for the classification of commercially confidential information and personal data in MAAs

April 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Heads of Medicines Agencies(HMA) and the European Medicines Agency (EMA) have adopted a joint guidance document, providing a consistent …

News
Press release

Catalent Extends Development and Analytical Solutions Capabilities in Swindon, UK

April 3, 2012
Research and Development

Somerset, NJ – March 22, 2012 — Catalent Pharma Solutions today announces the completion of new Development and Analytical Solutions’ …

News
Press release
Bayer image

Bayer cancer drug meets Phase III goal

April 3, 2012
Research and Development, Sales and Marketing Bayer, Cancer, Glivec, Novartis, phase III, regorafenib

Bayer’s stomach cancer pill regorafenib has significantly improved progression free survival in late-stage patients. Results from the Phase III trial …

News

Life appoints new digital developer

April 3, 2012
Business Services, Medical Communications, Sales and Marketing Life, Nick Douglas

Life Healthcare Communications has created a new digital developer role, continuing the growth of its digital department.  The firm has …

Appointment

Standardised equipment and centralised spirometry for optimal data quality

April 3, 2012
Research and Development

IntroductionWhen developing the treatments for asthma and COPD, pharmaceutical companies utilise pulmonary function testing (PFT) to determine each compound’s efficacy. …

Feature
Thought Leadership

Considerations with dual site production

April 3, 2012
Research and Development

There are generally two options available when looking to expand storage capacity – build to develop existing facilities or select …

Feature
Thought Leadership

Novasep expands in China, raises €40m for investments

April 3, 2012
Manufacturing and Production China, Novasep, Shanghai, manufacturing

French processing equipment supplier Novasep has opened a new facility in China to meet what it says is increasing demand …

News

Pharma manufacturing news in brief

April 3, 2012
Manufacturing and Production Gerresheimer and Foster Wheeler, Pharmax, Sigma-Aldrich

Pharmax starts building Dubai plant, Brazil tightens gelatin controls, plus updates from Sigma-Aldrich, Gerresheimer and Foster Wheeler.

News

Michael Cola resigns from Shire

April 3, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Cola, Shire

Michael Cola has resigned as the president of Shire Specialty Pharmaceuticals after seven years at the firm.  “On behalf of …

Appointment
Halaven image

NICE rejects Halaven for breast cancer

April 3, 2012
Sales and Marketing Eisai, Halaven, NICE, breast cancer

NICE has rejected Eisai’s novel breast cancer drug Halaven, due to concerns over its safety and costs.  In its final …

News

Moving Towards a Risk-Based approach to Clinical Trial Management

April 3, 2012
Research and Development

Clinical trials need to be managed to rigorous standards in order to secure the quality and integrity of every aspect …

Feature
Thought Leadership

Universal WorldEvents Marks Anniversary with Increase in Events

April 2, 2012
Sales and Marketing

Universal WorldEvents has marked its first anniversary by revealing a significant increase in the number of events organised by the …

News
Press release

Novartis to construct pharma plant in Turkey

April 2, 2012
Manufacturing and Production Novartis, Turkey, manufacturing

Novartis has selected Turkey as its headquarters for central Asia, the Middle East and Africa and intends to set up …

News

AstraZeneca wins fresh US victory with Seroquel XR

April 2, 2012
Sales and Marketing AZ, AstraZeneca, FDA, Seroquel XR

AstraZeneca is celebrating a US court verdict in its ongoing battle for intellectual property over the extended release version of …

News

Piramal opens ADC plant in Scotland

April 2, 2012
Manufacturing and Production ADC, Abbott, Piramel

India’s Piramal Healthcare has officially opened a new production unit to make antibody-drug conjugates at its facility in Grangemouth, Scotland. …

News
Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012
Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …

News
Roche image

Roche raises Illumina bid to $6.7 billion

April 2, 2012
Sales and Marketing

Roche has increased its takeover bid for Illumina, with the offer now valuing the company at $6.7 billion.The firm makes …

News
Teva image

Teva sells Canadian plant to CMO

March 30, 2012
Manufacturing and Production CMO, Halo Pharmaceutical, Teva, manufacturing

Teva has said it plans to sell a manufacturing facility in Quebec, Canada, to US contract manufacturing organisation Halo Pharmaceutical. …

News

Amylin dismisses BMS acquisition deal

March 30, 2012
Manufacturing and Production, Sales and Marketing Amylin, BMS, Bydureon, diabetes, lilly

Amylin Pharmaceuticals has rebuffed a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb, according to reports. Shares in Amylin rose …

News
michael_holston-1-3001

Merck appoints new chief ethics and compliance officer

March 30, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bowles, Holston, MSD, Merck

Merck has announced the appointment of Michael Holston as chief ethics and compliance officer. Holston is to succeed Richard Bowles, …

Appointment
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026